ASO Author Reflections: The "New Normal" in Cancer Clinical Trials in the Post-Pandemic Era

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
² Lakeland Regional Health, Lakeland, FL, USA.
³ Division of Surgical Oncology, East Carolina University Brody School of Medicine, Greenville, NC, USA.
⁴ Department of Surgery, Mayo Clinic, Rochester, MN, USA. Boughey.judy@mayo.edu.

Comment

Akhil Chawla et al. Ann Surg Oncol. 2021 Nov.

. 2021 Nov;28(12):7317-7318.

doi: 10.1245/s10434-021-10545-6. Epub 2021 Jul 31.

¹ Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
² Lakeland Regional Health, Lakeland, FL, USA.
³ Division of Surgical Oncology, East Carolina University Brody School of Medicine, Greenville, NC, USA.
⁴ Department of Surgery, Mayo Clinic, Rochester, MN, USA. Boughey.judy@mayo.edu.

No abstract available

Comment on

Impact of the COVID-19 Pandemic on Cancer Clinical Trials.
Boughey JC, Snyder RA, Kantor O, Zheng L, Chawla A, Nguyen TT, Hillman SL, Hahn OM, Mandrekar SJ, Roland CL. Boughey JC, et al. Ann Surg Oncol. 2021 Nov;28(12):7311-7316. doi: 10.1245/s10434-021-10406-2. Epub 2021 Jul 8. Ann Surg Oncol. 2021. PMID: 34236550 Free PMC article.

1. Nipp RD, Hong K, Paskett ED. Overcoming barriers to clinical trial enrollment. Am Soc Clin Oncol Educ Book. 2019;39:105–114. doi: 10.1200/EDBK_243729. - DOI - PubMed
1. Unger JM, Xiao H. The COVID-19 pandemic and new clinical trial activations. Trials. 2021;22(1):260. doi: 10.1186/s13063-021-05219-3. - DOI - PMC - PubMed
1. Boughey J, Snyder R, Kantor O, et al. Impact of COVID-19 pandemic on cancer clinical trials. Ann Surg Oncol. 2021;1–6. 10.1245/s10434-021-10406-2. - PMC - PubMed